These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 11781835)
1. The critical role of the PE21 element in oncostatin M-mediated transcriptional repression of the p53 tumor suppressor gene in breast cancer cells. Li C; Ahlborn TE; Tokita K; Boxer LM; Noda A; Liu J Oncogene; 2001 Dec; 20(57):8193-202. PubMed ID: 11781835 [TBL] [Abstract][Full Text] [Related]
2. The expression of p53 tumor suppressor gene in breast cancer cells is down-regulated by cytokine oncostatin M. Liu J; Li C; Ahlborn TE; Spence MJ; Meng L; Boxer LM Cell Growth Differ; 1999 Oct; 10(10):677-83. PubMed ID: 10547071 [TBL] [Abstract][Full Text] [Related]
3. A unique, short sequence determines p53 gene basal and UV-inducible expression in normal human cells. Noda A; Toma-Aiba Y; Fujiwara Y Oncogene; 2000 Jan; 19(1):21-31. PubMed ID: 10644976 [TBL] [Abstract][Full Text] [Related]
4. Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene. Liu J; Spence MJ; Wallace PM; Forcier K; Hellström I; Vestal RE Cell Growth Differ; 1997 Jun; 8(6):667-76. PubMed ID: 9186000 [TBL] [Abstract][Full Text] [Related]
5. Oncostatin M-mediated transcriptional suppression of the c-myc gene in breast cancer cells. Spence MJ; Vestal RE; Liu J Cancer Res; 1997 Jun; 57(11):2223-8. PubMed ID: 9187125 [TBL] [Abstract][Full Text] [Related]
6. Blockage of oncostatin M-induced LDL receptor gene transcription by a dominant-negative mutant of C/EBPbeta. Zhou Y; Zhang F; Abidi P; Lin M; Thiel G; Liu J Biochem J; 2006 Jul; 397(1):101-8. PubMed ID: 16563127 [TBL] [Abstract][Full Text] [Related]
7. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion. Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833 [TBL] [Abstract][Full Text] [Related]
8. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer. Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053 [TBL] [Abstract][Full Text] [Related]
9. Delineating an oncostatin M-activated STAT3 signaling pathway that coordinates the expression of genes involved in cell cycle regulation and extracellular matrix deposition of MCF-7 cells. Zhang F; Li C; Halfter H; Liu J Oncogene; 2003 Feb; 22(6):894-905. PubMed ID: 12584569 [TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta. Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749 [TBL] [Abstract][Full Text] [Related]
11. Molecular mechanism of transcriptional repression of gelsolin in human breast cancer cells. Dong Y; Asch HL; Ying A; Asch BB Exp Cell Res; 2002 Jun; 276(2):328-36. PubMed ID: 12027462 [TBL] [Abstract][Full Text] [Related]
12. Human mucin 1 oncoprotein represses transcription of the p53 tumor suppressor gene. Wei X; Xu H; Kufe D Cancer Res; 2007 Feb; 67(4):1853-8. PubMed ID: 17308127 [TBL] [Abstract][Full Text] [Related]
13. Induction of Egr-1 by oncostatin M precedes up-regulation of low density lipoprotein receptors in HepG2 cells. Liu J; Shoyab M; Grove RI Cell Growth Differ; 1993 Jul; 4(7):611-6. PubMed ID: 8398902 [TBL] [Abstract][Full Text] [Related]
14. Cell type-specific bidirectional regulation of the glucocorticoid-induced leucine zipper (GILZ) gene by estrogen. Tynan SH; Lundeen SG; Allan GF J Steroid Biochem Mol Biol; 2004 Aug; 91(4-5):225-39. PubMed ID: 15336700 [TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of a cAMP-responsive element in the region upstream from promoter 1.3 of the human aromatase gene. Zhou D; Chen S Arch Biochem Biophys; 1999 Nov; 371(2):179-90. PubMed ID: 10545204 [TBL] [Abstract][Full Text] [Related]
16. Cyclopentenone causes cell cycle arrest and represses cyclin D1 promoter activity in MCF-7 breast cancer cells. Hsiang CH; Straus DS Oncogene; 2002 Mar; 21(14):2212-26. PubMed ID: 11948404 [TBL] [Abstract][Full Text] [Related]
17. The UV responsive elements in the human mimecan promoter: a functional characterization. Tasheva ES; Conrad GW Mol Vis; 2003 Jan; 9():1-9. PubMed ID: 12533723 [TBL] [Abstract][Full Text] [Related]
18. Introduction of p16INK4a inhibits telomerase activity through transcriptional suppression of human telomerase reverse transcriptase expression in human gliomas. Saito M; Nakagawa K; Hamada K; Hirose S; Harada H; Kohno S; Nagato S; Ohnishi T Int J Oncol; 2004 May; 24(5):1213-20. PubMed ID: 15067344 [TBL] [Abstract][Full Text] [Related]
19. ING1 represses transcription by direct DNA binding and through effects on p53. Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900 [TBL] [Abstract][Full Text] [Related]
20. Synergistic and opposing regulation of the stress-responsive gene IEX-1 by p53, c-Myc, and multiple NF-kappaB/rel complexes. Huang YH; Wu JY; Zhang Y; Wu MX Oncogene; 2002 Oct; 21(44):6819-28. PubMed ID: 12360408 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]